Triple Targeted efficacy for oily-combination, blemish-prone skin. Targets blackheads, blemishes and post-acne marks, even severe, stubborn imperfections. Gently exfoliates with Salicylic Acid to unclog pores and help prevent spots & breakouts.
Tested on all skin tones, also suitable for those who may be prone to acne.
SPECIFICALLY FORMULATED FOR
Specifically formulated for oily-combination skin, adults and teenagers. Even severe cases and all skin tones. Suitable for use from 10 years old+. Also suitable for those who may be prone to acne. This is a cosmetic product. For medical conditions seek advice from your GP.
DERMATOLOGICALLY TESTED
This gentle moisturiser has been through testing under dermatological control. It is non-comedogenic and is also suitable for use for those who may be prone to acne.
Suitable for
All skin types.
Suitable for use from 10 years old+
How to use
1. Cleanse with Effaclar Purifying Foaming Gel
2. Moisturise with Effaclar Duo + M, applying this product morning and evening to the entire face avoiding the eye area.
3. Protect with Anthelios UVMune 400 Oil Control SPF50.
Active ingredients
Salicylic Acid
Ingredients
AQUA / WATER / EAU • GLYCERIN • DIMETHICONE • ISOCETYL STEARATE • NIACINAMIDE • ISOPROPYL L A U R O Y L S A R C O S I N AT E • S I L I C A • AMMONIUM POLYACRYLOYLDIMETHYL TAURATE • ORYZA SATIVA STARCH / RICE STARCH • PUNICA GRANATUM PERICARP EXTRACT • POTASSIUM CETYL PHOSPHATE • SORBITAN OLEATE • ZINC PCA • GLYCERYL STEARATE SE • ISOHEXADECANE • SODIUM HYDROXIDE • MYRISTYL MYRISTATE • 2-OLEAMIDO-1,3-OCTADECANEDIOL • M A N N O S E • P O L O X A M E R 3 3 8 • PROPANEDIOL • HYDROXYETHOXYPHENYL BUTANONE • CAPRYLOYL SALICYLIC ACID • C A P RY LY L G LY C O L • V I T R E O S C I L L A FERMENT • CITRIC ACID • TRISODIUM E T H Y L E N E D I A M I N E D I S U C C I N AT E • M A LT O D E X T R I N • X A N T H A N G U M • PENTYLENE GLYCOL • POLYSORBATE 80 • A C R Y L A M I D E / S O D I U M ACRYLOYLDIMETHYLTAURATE COPOLYMER • SALICYLIC ACID • PIROCTONE OLAMINE • P A R F U M / F R A G R A N C E .